Literature DB >> 2996002

In vitro growth characteristics of simian T-lymphotropic virus type III.

M Kannagi, J M Yetz, N L Letvin.   

Abstract

The type C retrovirus simian T-lymphotropic virus type III (STLV-III) has been isolated recently from immunodeficient macaque monkeys at the New England Regional Primate Research Center. The present studies were done to define the in vitro growth characteristics of this agent. STLV-III replicates efficiently in interleukin 2-dependent T-cell cultures of macaque peripheral blood lymphocytes (PBL), less efficiently in such cultures of human and gibbon PBL, and inefficiently in baboon PBL. No replication, as assessed by measuring reverse transcriptase activity in these culture supernatants, could be detected in similarly maintained cultures of chimpanzee, squirrel monkey, and cotton-top tamarin PBL. Like the human acquired immunodeficiency syndrome (AIDS) virus, human T-cell lymphotropic virus III/lymphadenopathy-associated virus (HTLV-III/LAV), STLV-III replicates in T4+ but not T8+ lymphocytes and its infection of macaque and human lymphocytes can be blocked with monoclonal anti-T4 antibodies. STLV-III differs from the human AIDS virus, however, in its apparent inability to grow in the Epstein-Barr virus-transformed B lymphocytes tested, the differing range of nonhuman primate T-cell populations that support its growth, and its less striking toxicity for T lymphocytes. These studies provide further characterization of an agent that will be extremely important in facilitating the development of vaccines and antiviral therapy for AIDS.

Entities:  

Mesh:

Year:  1985        PMID: 2996002      PMCID: PMC391308          DOI: 10.1073/pnas.82.20.7053

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  12 in total

1.  HTLV-III, LAV, ARV are variants of same AIDS virus.

Authors:  L Ratner; R C Gallo; F Wong-Staal
Journal:  Nature       Date:  1985 Feb 21-27       Impact factor: 49.962

Review 2.  NIH conference. The acquired immunodeficiency syndrome: an update.

Authors:  A S Fauci; H Masur; E P Gelmann; P D Markham; B H Hahn; H C Lane
Journal:  Ann Intern Med       Date:  1985-06       Impact factor: 25.391

3.  Clinical and pathologic features of an acquired immune deficiency syndrome (AIDS) in macaque monkeys.

Authors:  N L Letvin; N W King
Journal:  Adv Vet Sci Comp Med       Date:  1984

4.  Transmission of naturally occurring lymphoma in macaque monkeys.

Authors:  R D Hunt; B J Blake; L V Chalifoux; P K Sehgal; N W King; N L Letvin
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

5.  T lymphocyte surface antigens in primates.

Authors:  N L Letvin; N W King; E L Reinherz; R D Hunt; H Lane; S F Schlossman
Journal:  Eur J Immunol       Date:  1983-04       Impact factor: 5.532

6.  Experimental transmission of macaque AIDS by means of inoculation of macaque lymphoma tissue.

Authors:  N L Letvin; W R Aldrich; N W King; B J Blake; M D Daniel; R D Hunt
Journal:  Lancet       Date:  1983-09-10       Impact factor: 79.321

7.  Acquired immunodeficiency syndrome in a colony of macaque monkeys.

Authors:  N L Letvin; K A Eaton; W R Aldrich; P K Sehgal; B J Blake; S F Schlossman; N W King; R D Hunt
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

8.  Isolation of T-cell tropic HTLV-III-like retrovirus from macaques.

Authors:  M D Daniel; N L Letvin; N W King; M Kannagi; P K Sehgal; R D Hunt; P J Kanki; M Essex; R C Desrosiers
Journal:  Science       Date:  1985-06-07       Impact factor: 47.728

9.  A naturally occurring bone-marrow-chimeric primate. I. Integrity of its immune system.

Authors:  J Picus; W R Aldrich; N L Letvin
Journal:  Transplantation       Date:  1985-03       Impact factor: 4.939

10.  Histopathologic changes in macaques with an acquired immunodeficiency syndrome (AIDS).

Authors:  N W King; R D Hunt; N L Letvin
Journal:  Am J Pathol       Date:  1983-12       Impact factor: 4.307

View more
  42 in total

Review 1.  Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1.

Authors:  A D Kashuba; J R Dyer; L M Kramer; R H Raasch; J J Eron; M S Cohen
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

2.  Nuclear factors that bind two regions important to transcriptional activity of the simian immunodeficiency virus long terminal repeat.

Authors:  S Winandy; B Renjifo; Y Li; N Hopkins
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

3.  Isolation from African Sykes' monkeys (Cercopithecus mitis) of a lentivirus related to human and simian immunodeficiency viruses.

Authors:  P Emau; H M McClure; M Isahakia; J G Else; P N Fultz
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

4.  Comparison of the transcriptional activity of the long terminal repeats of simian immunodeficiency viruses SIVmac251 and SIVmac239 in T-cell lines and macrophage cell lines.

Authors:  M G Anderson; J E Clements
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

5.  Envelope vaccination shapes viral envelope evolution following simian immunodeficiency virus infection in rhesus monkeys.

Authors:  Aravind Basavapathruni; Wendy W Yeh; Rory T Coffey; James B Whitney; Peter T Hraber; Ayush Giri; Bette T Korber; Srinivas S Rao; Gary J Nabel; John R Mascola; Michael S Seaman; Norman L Letvin
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

6.  Induction of phosphorylation of human immunodeficiency virus type 1 Nef and enhancement of CD4 downregulation by phorbol myristate acetate.

Authors:  T Luo; J R Downing; J V Garcia
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

7.  Utilization of C-C chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian immunodeficiency virus, SIVmac239.

Authors:  L Marcon; H Choe; K A Martin; M Farzan; P D Ponath; L Wu; W Newman; N Gerard; C Gerard; J Sodroski
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

8.  AIDS in primates.

Authors:  A J Zuckerman
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-18

9.  Truncations of the simian immunodeficiency virus transmembrane protein confer expanded virus host range by removing a block to virus entry into cells.

Authors:  P B Johnston; J W Dubay; E Hunter
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

10.  Restricted replication of simian immunodeficiency virus strain 239 in macrophages is determined by env but is not due to restricted entry.

Authors:  K Mori; D J Ringler; R C Desrosiers
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.